Abstract:BACKGROUND:The role of naturally occurring regulatory T cells (Treg) in the control of the development of systemic lupus erythematosus (SLE) has not been well defined. Therefore, we dissect the phenotypically heterogeneous CD4(+)FoxP3(+) T cells into subpopulations during the dynamic SLE development. METHODLOGY/PRINCIPAL FINDINGS: To evaluate the proliferative and suppressive capacities of different CD4(+) T cell subgroups between active SLE patients and healthy donors, we employed CD45RA and CD25 as surface markers and carboxyfluorescein diacetatesuccinimidyl ester (CFSE) dilution assay. In addition, multiplex cytokines expression in active SLE patients was assessed using Luminex assay. Here, we showed a significant increase in the frequency of CD45RA(+)FoxP3(low) naive Treg cells (nTreg cells) and CD45RA(-)FoxP3(low) (non-Treg) cells in patients with active SLE. In active SLE patients, the increased proportions of CD45RA(+)FoxP3(low) nTreg cells were positively correlated with the disease based on SLE disease activity index (SLEDAI) and the status of serum anti-dsDNA antibodies. We found that the surface marker combination of CD25(+)CD45RA(+) can be used to defined CD45RA(+)FoxP3(low) nTreg cells for functional assays, wherein nTreg cells from active SLE patients demonstrated defective suppression function. A significant correlation was observed between inflammatory cytokines, such as IL-6, IL-12 and TNFα, and the frequency of nTreg cells. Furthermore, the CD45RA(+)FoxP3(low) nTreg cell subset increased when cultured with SLE serum compared to healthy donor serum, suggesting that the elevated inflammatory cytokines of SLE serum may promote nTreg cell proliferation/expansion.CONCLUSIONS/SIGNIFICANCE:Our results indicate that impaired numbers of functional CD45RA(+)FoxP3(low) naive Treg cell and CD45RA(-)FoxP3(low) non-suppressive T cell subsets in inflammatory conditions may contribute to SLE development. Therefore, analysis of subsets of FoxP3(+) T cells, using a combination of FoxP3, CD25 and CD45RA, rather than whole FoxP3(+) T cells, will help us to better understand the pathogenesis of SLE and may lead to the development of new therapeutic strategies.

Nonspecific increase of αβTCR+ double-negative T cells in pediatric rheumatic diseases

Double-negative T cells in pediatric rheumatic diseases

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

Peripheral CD24hi CD27+ CD19+ B Cells Subset As a Potential Biomarker in Naïve Systemic Lupus Erythematosus.

Double-Negative T (DNT) Cells in Patients with Systemic Lupus Erythematosus

Revisiting double-negative T cells in autoimmune lymphoproliferative immunodeficiencies: a case series

Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients

Phosphatidic Acid Promoting the Generation of Interleukin-17A Producing Double-Negative T Cells by Enhancing Mtorc1 Signaling in Lupus

Expansion of extrafollicular B and T cell subsets in childhood-onset systemic lupus erythematosus

Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells

Increased CD45RA+ FoxP3(low) Regulatory T Cells with Impaired Suppressive Function in Patients with Systemic Lupus Erythematosus.

Phosphatidic acid promotes the generation of IL‐17A producing double‐negative T cell by enhancing mTORC1 signaling in lupus

Th22, but not Th17 Might be a Good Index to Predict the Tissue Involvement of Systemic Lupus Erythematosus

Increased Expression of Type 2 Innate Lymphoid Cells in Pediatric Patients with Allergic Rhinitis.

Activation of circulating TFH17 cells associated with activated naive and double negative 2 B cell expansion, and disease activity in systemic lupus erythematosus patients

Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway.

Transcriptome landscape of double negative T cells by single-cell RNA sequencing

T cell receptor β repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritis

Cell activation, PD-1 expression and in vitro cytokine production in patients with juvenile systemic lupus erythematosus

Association between peripheral activated naive and double negative 2 B‐cell subsets and clinical parameters in lupus nephritis patients

KAT2B expression on CD4+T lymphocytes in pediatric systemic lupus erythematosus